Document is current
Any future updates will be listed below
-
Authors
Chen, Yifan
Zhou, Yanjie
Zhou, Zhongshu
Fang, Yujiang
Ma, Lin
Zhang, Xiaoqing http://orcid.org/0000-0002-7405-1893
Xiong, Jie
Liu, Ling
-
Funding
Funding for this research was provided by:
Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone (ZJ2018-ZD-004)
Science and Technology Commission of Shanghai Municipality (19JC1415100, 21140902300)
National Key Research and Development Program of China (2018YFA0108000, 2019YFA0110300, 2021YFA1100400, 2021YFC2701400)
National Natural Science Foundation of China (82025020, 32000689, 31872760, 82230072, 32270874)
- License Information
-
More Information
Article History
Received: 28 January 2022
Accepted: 28 December 2022
First Online: 24 January 2023
Declarations
:
: All animal experiments were conducted in accordance with the Guide for the Care and Use of Animals for Research Purposes. All the procedures were approved by the Ethics Committee of Shanghai East Hospital, School of Medicine, Tongji University (Neural development and regeneration, 2020YANYUSHEN093, 2020-03-23; In vitro lineage differentiation potency and in vivo transplantation studies of engineered hypoimmunogenic pluripotent stem cells, 2022YANYUSHEN026, 2022-03-01).
: Not applicable.
: The authors declare no competing interests.
